Idiopathic Pleuroparenchymal Fibroelastosis.
Dyspnea
Hypoxia
Idiopathic pleuroparenchymal fibroelastosis
Interstitial lung disease
Interstitial pneumonia
Platythorax
Pneumomediastinum
Pneumothorax
Journal
Journal of medical cases
ISSN: 1923-4163
Titre abrégé: J Med Cases
Pays: Canada
ID NLM: 101551824
Informations de publication
Date de publication:
May 2022
May 2022
Historique:
received:
28
03
2022
accepted:
21
04
2022
entrez:
3
6
2022
pubmed:
4
6
2022
medline:
4
6
2022
Statut:
ppublish
Résumé
Idiopathic pleuroparenchymal fibroelastosis (IPPFE) is a rare form of idiopathic interstitial pneumonia. The disease is characterized by fibrosis of the pleura and subpleural lung parenchyma predominantly affecting the upper lobes. Various triggers have been proposed as inciting factors in the development of the disease. Diagnosis is made clinically in conjunction with radiographic findings and histopathology when available. There are no known effective treatment options and several cases of lung transplantation have been reported. We report a case of an 86-year-old female who presented to the emergency department with worsening dyspnea and hypoxia. She had a history of unexplained pneumomediastinum and a 20 - 25 pounds unintentional weight loss over 10 months. Computed tomography (CT) of the chest without contrast revealed radiographic evidence of IPPFE. Despite symptomatic management with antibiotics, diuretics, and steroids, her condition continued to deteriorate. Unfortunately, our patient was not a candidate for a lung transplant. She was transitioned to hospice care and succumbed to her disease. IPPFE is a rare disease with an unknown prevalence. It has a median survival rate of 2 years. Usually, there is an overlap with interstitial lung diseases, making it challenging to diagnose. There are only a few cases reported in the literature, and there are currently no guidelines available on the appropriate management of this debilitating disease. We recommend more cases be reported, and further research is done to establish better criteria for diagnosis and management.
Identifiants
pubmed: 35655629
doi: 10.14740/jmc3927
pmc: PMC9119366
doi:
Types de publication
Case Reports
Langues
eng
Pagination
235-239Informations de copyright
Copyright 2022, Tavakolian et al.
Déclaration de conflit d'intérêts
None to declare.
Références
Curr Respir Med Rev. 2013 Jun;9:299-237
pubmed: 24578677
Ann Thorac Surg. 2014 Nov;98(5):e115-7
pubmed: 25441830
Transplant Proc. 2019 Jan - Feb;51(1):235-238
pubmed: 30655147
Eur Respir J. 2012 Aug;40(2):377-85
pubmed: 22441748
J Heart Lung Transplant. 2005 Sep;24(9):1260-8
pubmed: 16143243
Mod Pathol. 2008 Jun;21(6):784-7
pubmed: 18408658
Resuscitation. 2006 Dec;71(3):387-90
pubmed: 16982125
Respir Med Case Rep. 2014 Mar 14;12:7-9
pubmed: 26029526
Mod Pathol. 2011 Dec;24(12):1633-9
pubmed: 21822205
Ann Am Thorac Soc. 2019 Nov;16(11):1351-1359
pubmed: 31425665
Can Respir J. 2018 Aug 13;2018:6043053
pubmed: 30186537
Respiration. 2019;97(4):319-328
pubmed: 30522096
Eur Respir J. 2017 May 11;49(5):
pubmed: 28495689
Histopathology. 2015 Mar;66(4):545-54
pubmed: 25234959
Am J Respir Crit Care Med. 2013 Sep 15;188(6):733-48
pubmed: 24032382